HCW BIOLOGICS INC (HCWB) Stock Analyst Earnings Estimates
NASDAQ:HCWB - Nasdaq - US40423R1059 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 6.72M | 2.842M -57.71% | 9.355M 229.19% | -100.00% | 54.427M | 163.72M 200.81% | 378.05M 130.91% | 642.3M 69.90% | ||
| EBITDA YoY % growth | -12.83M -145.79% | -14.36M -11.93% | -24.582M -71.18% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -13.37M -129.73% | -15.08M -12.79% | -25.717M -70.54% | -22.53M 12.39% | -28.935M -28.43% | -37.616M -30.00% | 8.509M 122.62% | 66.189M 677.87% | 236.23M 256.90% | 441.01M 86.69% | |
| Operating Margin | N/A | -224.40% | -904.96% | -240.83% | N/A | N/A | 15.63% | 40.43% | 62.49% | 68.66% | |
| EPS YoY % growth | N/A | -0.42 46.17% | -0.70 -66.67% | -0.58 16.94% | -0.56 3.51% | -0.55 1.82% | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | 0.09 130.60% |
| Revenue Q2Q % growth | 7.14M 439.27% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | 4.317M 140.09% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -0.30 -100.00% | -0.14 | -0.16 | -110.08% |
| Q3 2023 Q2Q % growth | -0.14 -27.27% | -0.13 | -0.01 | -5.58% |
| Q2 2023 Q2Q % growth | -0.12 -20.00% | -0.15 | 0.03 | 19.79% |
| Q1 2023 Q2Q % growth | -0.14 -133.33% | -0.14 | 0.00 | 1.96% |
| Q4 2022 Q2Q % growth | -0.15 11.24% | -0.17 | 0.02 | 10.87% |
| Q3 2022 Q2Q % growth | -0.11 | -0.12 | 0.01 | 10.13% |
| Q2 2022 Q2Q % growth | -0.10 | -0.13 | 0.03 | 21.57% |
| Q1 2022 Q2Q % growth | -0.06 | -0.11 | 0.05 | 46.52% |
| Q4 2021 Q2Q % growth | -0.17 | -0.12 | -0.05 | -38.07% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 426.42K -50.01% | % | ||
| Q2 2024 Q2Q % growth | 618.85K -0.51% | % | ||
| Q1 2024 Q2Q % growth | 1.127M 2,590.33% | % | ||
| Q4 2023 Q2Q % growth | 1.324M -1.19% | 918K | 406K | 44.23% |
| Q3 2023 Q2Q % growth | 853K -52.87% | 306K | 547K | 178.76% |
| Q2 2023 Q2Q % growth | 622K 38.22% | 622K | % | |
| Q1 2023 Q2Q % growth | 41.88K -98.66% | 1.173M | -1.131M | -96.43% |
| Q4 2021 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 0% | 713.48% |